DYADIC INTERNATIONAL INC Retained Earnings
DYADIC INTERNATIONAL INC (DYAI) had Retained Earnings of -$97.53 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-12
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$97.53M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$95.41M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$93.45M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$91.88M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$97.53M 10-Q · filed 2026-08-12 |
| 2026-03-31 | -$95.41M 10-Q · filed 2026-05-13 |
| 2025-12-31 | -$93.45M 10-Q · filed 2026-08-12 |
| 2025-09-30 | -$91.88M 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$89.91M 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$88.11M 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$86.09M 10-K · filed 2026-03-25 |
| 2024-09-30 | -$84.54M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$84.33M 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$82.29M 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$80.28M 10-K · filed 2025-03-26 |
| 2023-09-30 | -$78.21M 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$76.59M 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$74.44M 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$73.48M 10-K · filed 2024-03-28 |
| 2022-09-30 | -$71.34M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$69.53M 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$66.24B 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$63.75M 10-K · filed 2023-03-29 |
| 2021-09-30 | -$59.53M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$57.82M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$53.97M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$50.68M 10-K · filed 2022-03-29 |
| 2020-09-30 | -$48.72M 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$46.22M 10-Q · filed 2020-08-13 |
| 2020-03-31 | -$43.57M 10-Q · filed 2020-05-14 |
| 2019-12-31 | -$41.35M 10-K · filed 2021-03-30 |
| 2019-09-30 | -$39.61M 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$37.91M 10-Q · filed 2019-08-13 |
| 2019-03-31 | -$35.22M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$33.04M 10-K · filed 2020-03-30 |
| 2017-12-31 | -$27.35M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |